Clinical trial
Stereotactic Body RadioTherapy (SBRT) for Oligo-metastatic Colo-rectal Cancer With Bio-marker Evaluation for Early Progression
NCT03175146 is registered in ClinicalTrials.gov with AHS Cancer Control Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stereotactic Body RadioTherapy (SBRT) for Oligo-metastatic Colo-rectal Cancer With Bio-marker Evaluation for Early Progression
- Lead sponsor
- AHS Cancer Control Alberta
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2017
- Completion date
- January 31, 2021
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.